Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03229286
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.71 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.77 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.75 | |
THC | N-METHYLCARBONYLTHREONINE | A,B,C | 1A7C | 0.86 | |
THC | N-METHYLCARBONYLTHREONINE | B | 2HR0 | 0.86 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 2MPA | 0.86 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 1MPA | 0.86 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.8 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 3HY7 | 0.73 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 2JIH | 0.73 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A | 1R55 | 0.73 | |
HLU | BETA-HYDROXYLEUCINE | A | 1ROV | 0.7 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.72 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.8 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.72 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.76 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.76 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.71 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.71 | |
76V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.75 | |
TMD | (6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N- DIMETHYL-THREONINE | C | 1CWK | 0.72 | |
N10 | O-[(HEXYLAMINO)CARBONYL]-L-SERINE | A,B,C,D,E,F, G,H | 2Q0S | 0.71 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.87 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.87 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.87 | |
168 | PANTOTHENYL-AMINOETHANOL-ACETATE PIVALIC ACID | A,B,C,D | 1OU6 | 0.72 | |
PAU | PANTOTHENOIC ACID | A,B | 2F9W | 0.76 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BF1 | 0.76 | |
PAU | PANTOTHENOIC ACID | A,B,C,D | 1SQ5 | 0.76 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BEX | 0.76 | |
OPI | PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID | A,B,C,D | 2VU1 | 0.74 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.74 | |
C99 | {(2R)-2-[(1S,2R)-1-AMINO-2-HYDROXYPROPYL]- 2-HYDROXY-4,5-DIOXOIMIDAZOLIDIN- 1-YL}ACETIC ACID | A | 2HCG | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.77 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.77 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.73 | |
PT3 | N-PROPYL-TARTRAMIC ACID | A,B,C,D | 2HPA | 0.72 | |
CDV | 3-METHYL-2-UREIDO-BUTYRIC ACID | B | 1UF7 | 0.72 | |
PCV | 5-AMINO-3-HYDROXY-2-(2-OXO-AZETIDIN- 1-YL)-PENTANOIC ACID | A | 1DRT | 0.74 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.8 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1AEC | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 2PRE | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1CV8 | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 3C9E | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 3BCN | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1ATK | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 3BPF | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1TLO | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1QX6 | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1MEG | 0.78 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 2BDZ | 0.78 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B80 | 0.87 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B7V | 0.87 | |
SUJ | (2R,3R)-2-[(3S,6R)-3-AMINO-6-HYDROXY- 2-OXOPIPERIDINYL]-3-HYDROXYBUTANOIC ACID | C,D | 1OKX | 0.78 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.73 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.76 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.74 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.74 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,Q,S,T,V,W,Z | 2EIL | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,Q,S,T,V,W,Z | 2DYR | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,S,T,V,W,Z | 2EIM | 0.79 | |
SAC | N-ACETYL-SERINE | A | 1R4U | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 1WS3 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,E,F, G,H | 1XY3 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B | 1EVU | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,E,F, G,H | 1R56 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,S,T,V,W,Z | 2DYS | 0.79 | |
SAC | N-ACETYL-SERINE | A | 1WRR | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,E,F, G,I,J,L,M,N, O,P,Q,S,T,V, W,Z | 1V54 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B | 3CVQ | 0.79 | |
SAC | N-ACETYL-SERINE | A | 1B0B | 0.79 | |
SAC | N-ACETYL-SERINE | A | 1XT4 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,F,G,I, J,L,M,N,O,P, S,T,V,W,Z | 2EIJ | 0.79 | |
SAC | N-ACETYL-SERINE | A | 2FXL | 0.79 | |
SAC | N-ACETYL-SERINE | A | 1R4S | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 1WS2 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 2AUC | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,S,T,V,W,Y,Z | 2EIN | 0.79 | |
SAC | N-ACETYL-SERINE | A | 1R51 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,E,F,G, I,J,M,N,O,P, Q,S,T,V,W,Z | 1V55 | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 1XXJ | 0.79 | |
SAC | N-ACETYL-SERINE | T | 2QAC | 0.79 | |
SAC | N-ACETYL-SERINE | A,B,C,E,F,G, I,J,L,M,N,O, P,Q,S,T,V,W, Y,Z | 2EIK | 0.79 | |
59A | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCINE | A | 2DC8 | 0.73 | |
FEB | N~2~-[(3R)-3-hydroxydodecanoyl]- L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)- 3-methylbutyl]-L-glutamamide | 2,H,K,N,V,Y | 3D29 | 0.7 |